Holdings
Decheng Capital LLC
As of Jun 30, 2026, Decheng Capital LLC reported 12 positions worth US$716M. Largest: Cg Oncology, Inc., Nuvation Bio Inc. and Aardvark Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cg Oncology, Inc. | 6.37M | US$453M | no change | Jun 30, 2026 |
| Nuvation Bio Inc. | 26M | US$147M | no change | Jun 30, 2026 |
| Aardvark Therapeutics, Inc. | 3.92M | US$22.6M | no change | Jun 30, 2026 |
| Aclaris Therapeutics, Inc. | 4.04M | US$21.4M | no change | Jun 30, 2026 |
| Upstream Bio, Inc. | 2.72M | US$18.9M | no change | Jun 30, 2026 |
| Arcus Biosciences, Inc. | 465K | US$14.3M | −13,040 | Jun 30, 2026 |
| Equillium, Inc. | 4.45M | US$14.2M | no change | Jun 30, 2026 |
| Revolution Medicines, Inc. | 52,667 | US$9.86M | −40,833 | Jun 30, 2026 |
| Beyondspring, Inc. | 3.8M | US$6.65M | no change | Jun 30, 2026 |
| Zentalis Pharmaceuticals, Inc. | 1.32M | US$6.42M | no change | Jun 30, 2026 |